Cargando…
Computational Design of New Peptide Inhibitors for Amyloid Beta (Aβ) Aggregation in Alzheimer's Disease: Application of a Novel Methodology
Alzheimer's disease is the most common form of dementia. It is a neurodegenerative and incurable disease that is associated with the tight packing of amyloid fibrils. This packing is facilitated by the compatibility of the ridges and grooves on the amyloid surface. The GxMxG motif is the major...
Autores principales: | Eskici, Gözde, Gur, Mert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675214/ https://www.ncbi.nlm.nih.gov/pubmed/23762479 http://dx.doi.org/10.1371/journal.pone.0066178 |
Ejemplares similares
-
Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation
por: Lu, Jinxia, et al.
Publicado: (2019) -
Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015) -
Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011) -
Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity
por: Kumar, Jitendra, et al.
Publicado: (2015) -
In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment
por: Job, Nisha, et al.
Publicado: (2023)